142 related articles for article (PubMed ID: 18813777)
1. Growth inhibitory effects of pegylated IFN-alpha2b and 5-fluorouracil in combination on renal cell carcinoma cell lines in vitro and in vivo.
Moriya F; Ogasawara S; Basaki Y; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Nishida N; Matsuoka K; Kojiro M; Kuwano M; Yano H
Int J Oncol; 2008 Oct; 33(4):647-55. PubMed ID: 18813777
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effects of pegylated IFN alpha-2b on human liver cancer cells in vitro and in vivo.
Yano H; Ogasawara S; Momosaki S; Akiba J; Kojiro S; Fukahori S; Ishizaki H; Kuratomi K; Basaki Y; Oie S; Kuwano M; Kojiro M
Liver Int; 2006 Oct; 26(8):964-75. PubMed ID: 16953837
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
4. Effects of pegylated interferon α2b on metastasis of hepatocellular carcinoma.
Arakawa Y; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T
J Surg Res; 2012 Jan; 172(1):95-101. PubMed ID: 20851413
[TBL] [Abstract][Full Text] [Related]
5. Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase.
Morita T; Tokue A
Cancer Chemother Pharmacol; 1999; 44(2):91-6. PubMed ID: 10412941
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitor augments anti-tumor effect of gemcitabine and pegylated interferon-α on pancreatic cancer cells.
Iwahashi S; Shimada M; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Mori H; Hanaoka J; Sugimoto K; Saito Y
Int J Clin Oncol; 2011 Dec; 16(6):671-8. PubMed ID: 21556798
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha2b and thalidomide synergistically inhibit tumor-induced angiogenesis.
Bauer JA; Morrison BH; Grane RW; Jacobs BS; Borden EC; Lindner DJ
J Interferon Cytokine Res; 2003 Jan; 23(1):3-10. PubMed ID: 12639293
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effects of sorafenib and pegylated IFN‑α2b on human liver cancer cells in vitro and in vivo.
Kusano H; Ogasawara S; Akiba J; Nakayama M; Ueda K; Yano H
Int J Oncol; 2013 Jun; 42(6):1897-903. PubMed ID: 23588838
[TBL] [Abstract][Full Text] [Related]
9. Biologic activity of polyethylene glycol12000-interferon-alpha2b compared with interferon-alpha2b: gene modulatory and antigrowth effects in tumor cells.
Vyas K; Brassard DL; DeLorenzo MM; Sun Y; Grace MJ; Borden EC; Leaman DW
J Immunother; 2003; 26(3):202-11. PubMed ID: 12806274
[TBL] [Abstract][Full Text] [Related]
10. Pegylated interferon-α2a inhibits proliferation of human liver cancer cells in vitro and in vivo.
Kusano H; Akiba J; Ogasawara S; Sanada S; Yasumoto M; Nakayama M; Ueda K; Ueda K; Kurita T; Todoroki K; Umeno Y; Nakashima O; Yano H
PLoS One; 2013; 8(12):e83195. PubMed ID: 24349459
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53.
Hagiwara S; Kudo M; Nakatani T; Sakaguchi Y; Nagashima M; Fukuta N; Kimura M; Hayakawa S; Munakata H
Br J Cancer; 2007 Dec; 97(11):1532-7. PubMed ID: 17971768
[TBL] [Abstract][Full Text] [Related]
12. Consensus interferon enhances the anti-proliferative effect of 5-fluorouracil on human hepatoma cells via downregulation of dihydropyrimidine dehydrogenase expression.
Dou J; Iwashita Y; Sasaki A; Kai S; Hirano S; Ohta M; Kitano S
Liver Int; 2005 Feb; 25(1):148-52. PubMed ID: 15698412
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor effects of various interferons-alpha +5-fluorouracil via downregulation of dihydropyrimidine dehydrogenase in hepatoma cells].
Fan XY; Uchida H; Iwaki K; Kai S; Shibata K; Ohta M; Kitano S
Gan To Kagaku Ryoho; 2007 Jun; 34(6):957-9. PubMed ID: 17565266
[TBL] [Abstract][Full Text] [Related]
15. Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo.
Chen S; Liang L; Wang Y; Diao J; Zhao C; Chen G; He Y; Luo C; Wu X; Zhang Y
Mol Med Rep; 2015 Nov; 12(5):6727-37. PubMed ID: 26300071
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha.
Kurokohchi K; Takaguchi K; Kita K; Masaki T; Kuriyama S
World J Gastroenterol; 2005 Sep; 11(34):5401-3. PubMed ID: 16149157
[TBL] [Abstract][Full Text] [Related]
17. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
18. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
19. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
[TBL] [Abstract][Full Text] [Related]
20. Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
Shang D; Ito N; Watanabe J; Awakura Y; Nishiyama H; Kamoto T; Ogawa O
Eur Urol; 2007 Oct; 52(4):1131-9. PubMed ID: 17275163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
